We are live on ! Find out more
CA

Crewe Advisors Portfolio holdings

AUM $1.38B
1-Year Est. Return 41.76%
This Fund
S&P 500
This Quarter Est. Return
-2.44%
1 Year Est. Return
+41.76%
3 Year Est. Return
+96.1%
5 Year Est. Return
+98.15%
10 Year Est. Return
–
AUM
$553M
AUM Growth
+$101M
Cap. Flow
+$126M
Cap. Flow %
22.75%
Top 10 Hldgs %
60.48%
Holding
1,303
New
138
Increased
595
Reduced
38
Closed
14

Top Buys

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$27.4M
2
VB icon
Vanguard Morningstar Small-Cap ETF
VB
+$19.7M
3
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$17.3M
4
AMD icon
Advanced Micro Devices
AMD
+$5.43M
5
TSLA icon
Tesla
TSLA
+$4.58M

Top Sells

Rank Stock Value
1
ENSG icon
The Ensign Group
ENSG
+$827K
2
PGX icon
Invesco Preferred ETF
PGX
+$734K
3
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$644K
4
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$137K
5
VSS icon
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
+$95K

Sector Composition

Rank Sector Weight
1 Healthcare 21.35%
2 Financials 7.74%
3 Technology 6.78%
4 Consumer Discretionary 4.25%
5 Energy 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IAA
926
DELISTED
IAA, Inc. Common Stock
IAA
$4K ﹤0.01%
126
-2,208
-95% -$78.4K
ZEN
927
DELISTED
ZENDESK INC
ZEN
$4K ﹤0.01%
50
+16
+47% +$1.21K
TEN
928
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$4K ﹤0.01%
211
– –
DRE
929
DELISTED
Duke Realty Corp.
DRE
$4K ﹤0.01%
76
+21
+38% +$1.23K
SBNY
930
DELISTED
Signature Bank
SBNY
$4K ﹤0.01%
28
+15
+115% +$2.73K
AMCR icon
931
Amcor
AMCR
$21.8B
$3K ﹤0.01%
+55
New +$3.37K
AMED
932
DELISTED
Amedisys
AMED
$3K ﹤0.01%
33
+10
+43% +$1.19K
AMG icon
933
Affiliated Managers Group
AMG
$9.58B
$3K ﹤0.01%
29
– –
ASTE icon
934
Astec Industries
ASTE
$1.01B
$3K ﹤0.01%
85
+49
+136% +$1.99K
OPTU
935
Optimum Communications Inc
OPTU
$412M
$3K ﹤0.01%
429
– –
BATRA icon
936
Atlanta Braves Holdings Series A
BATRA
$3.63B
$3K ﹤0.01%
100
– –
BCAB icon
937
BioAtla
BCAB
$5.2M
$3K ﹤0.01%
7
– –
BCS icon
938
Barclays
BCS
$91.1B
$3K ﹤0.01%
529
+7
+1% +$54
BIO icon
939
Bio-Rad Laboratories Class A
BIO
$10.4B
$3K ﹤0.01%
8
– –
BMEA icon
940
Biomea Fusion
BMEA
$124M
$3K ﹤0.01%
337
– –
BPMC
941
DELISTED
Blueprint Medicines
BPMC
$3K ﹤0.01%
50
– –
BXP icon
942
Boston Properties
BXP
$11.2B
$3K ﹤0.01%
38
– –
CADE
943
DELISTED
Cadence Bank
CADE
$3K ﹤0.01%
109
– –
CBRL icon
944
Cracker Barrel
CBRL
$1.31B
$3K ﹤0.01%
36
– –
CCJ icon
945
Cameco
CCJ
$46.8B
$3K ﹤0.01%
+99
New +$2.53K
CHGG icon
946
Chegg
CHGG
$87.7M
$3K ﹤0.01%
142
– –
CINF icon
947
Cincinnati Financial
CINF
$26.5B
$3K ﹤0.01%
+39
New +$4.02K
CNO icon
948
CNO Financial Group
CNO
$5.06B
$3K ﹤0.01%
168
– –
COLL icon
949
Collegium Pharmaceutical
COLL
$853M
$3K ﹤0.01%
197
– –
CPNG icon
950
Coupang
CPNG
$29.7B
$3K ﹤0.01%
200
– –
36 37
38
39 40

Similar funds

DPI
Diversified Portfolios Inc Bloomfield Hills, Michigan $1.38B AUM 14.49% 1-Year Est. Return
AIM
Advyzon Investment Management Lisle, Illinois $1.38B AUM 28.41% 1-Year Est. Return
TCA
Teewinot Capital Advisers New York $1.38B AUM 26.45% 1-Year Est. Return
DP
Dundas Partners Edinburgh, United Kingdom $1.38B AUM 28.73% 1-Year Est. Return
RG
Rakuten Group Setagaya-Ku, Tokyo, Japan $1.38B AUM 89.78% 1-Year Est. Return
KL
KWMG LLC Overland Park, Kansas $1.38B AUM 33.35% 1-Year Est. Return
PIMJS
PKO Investment Management Joint-Stock Warsaw, Poland $1.38B AUM 59.54% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return

Crewe Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Crewe Advisors held 1,303 positions worth $553M, up 22% from $453M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Crewe Advisors deployed $126M of net new capital in Q3 2022, opening 138 new positions and adding to 595 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 64 shares worth $26M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 25% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was The Ensign Group, an estimated $827K trimmed.

  • Crewe Advisors's largest Q3 2022 buy was Berkshire Hathaway Class A: 64 shares worth $26M.
  • Crewe Advisors added most to Vanguard Morningstar Small-Cap ETF in Q3 2022, an estimated $19.7M increase.
  • Crewe Advisors's biggest Q3 2022 reduction was The Ensign Group, cutting an estimated $827K.
  • Crewe Advisors fully exited Mantech International Corp in Q3 2022, selling an estimated $17K.
  • Crewe Advisors's ten largest holdings make up 60% of its $553M portfolio in Q3 2022.
  • Crewe Advisors opened 138 new positions and closed 14 in Q3 2022.
  • Crewe Advisors's portfolio value rose 22% quarter-over-quarter to $553M.

Based on Crewe Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.